Literature DB >> 16172029

LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of rats.

Ronald Schmidt1, Ovidiu Coste, Gerd Geisslinger.   

Abstract

For the determination of prostaglandins in microdialysis samples, usually immunoassays are used. However, these assays may show cross-reactivity among various prostaglandins. To overcome this problem a specific method for the determination of prostaglandin E2 and D2 in rat microdialysis samples by using liquid chromatography-electrospay ionization-tandem mass spectrometry (LC-ESI-MS/MS) is described. Prostaglandin E2 and D2 were extracted from microdialysis samples with liquid-liquid extraction using deuterated prostaglandin D2, [2H4]-PGD2, as internal standard. Subsequently, prostaglandins were separated with a phenomenex Synergi Hydro-RP column and determined with a PE Sciex API 3000 mass spectrometer equipped with a turbo ion spray interface operating in negative ionization mode. The method showed a LLOQ of 25 pg/ml for prostaglandin E2 and 50 pg/ml for prostaglandin D2. The applicability of the method is shown in rat spinal cord microdialysis samples following peripheral nociceptive stimulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172029     DOI: 10.1016/j.jchromb.2005.09.001

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  15 in total

1.  Accurate quantification of PGE2 in the polyposis in rat colon (Pirc) model by surrogate analyte-based UPLC-MS/MS.

Authors:  Changhong Yun; Wan-Mohaiza Dashwood; Lawrence N Kwong; Song Gao; Taijun Yin; Qinglan Ling; Rashim Singh; Roderick H Dashwood; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2017-07-25       Impact factor: 3.935

2.  LC/MS/MS method for analysis of E₂ series prostaglandins and isoprostanes.

Authors:  Stephen A Brose; Brock T Thuen; Mikhail Y Golovko
Journal:  J Lipid Res       Date:  2011-02-10       Impact factor: 5.922

3.  A fast one-step extraction and UPLC-MS/MS analysis for E2/D 2 series prostaglandins and isoprostanes.

Authors:  Stephen A Brose; Andrew G Baker; Mikhail Y Golovko
Journal:  Lipids       Date:  2013-02-12       Impact factor: 1.880

4.  An improved LC-MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids.

Authors:  Hongmei Cao; Lei Xiao; Gyeyoung Park; Xuerong Wang; Anser C Azim; John W Christman; Richard B van Breemen
Journal:  Anal Biochem       Date:  2007-09-29       Impact factor: 3.365

5.  Bioproduction of prostaglandins in a transgenic liverwort, Marchantia polymorpha.

Authors:  Miho Takemura; Hirosuke Kanamoto; Shingo Nagaya; Kanji Ohyama
Journal:  Transgenic Res       Date:  2013-03-05       Impact factor: 2.788

6.  Quantification of Prostaglandin E2 Concentration in Interstitial Fluid from the Hypothalamic Region of Free-moving Mice.

Authors:  Yoshinobu Nakamura; Takatoshi Sakaguchi; Ikumi Tamai; Takeo Nakanishi
Journal:  Bio Protoc       Date:  2019-08-05

7.  Spherical harmonics coefficients for ligand-based virtual screening of cyclooxygenase inhibitors.

Authors:  Quan Wang; Kerstin Birod; Carlo Angioni; Sabine Grösch; Tim Geppert; Petra Schneider; Matthias Rupp; Gisbert Schneider
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

8.  Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery--a pilot study.

Authors:  Bertold Renner; Josef Zacher; Asokumar Buvanendran; Gerrit Walter; Jochen Strauss; Kay Brune
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-01-06       Impact factor: 3.000

9.  COX-2-Derived Prostaglandin E2 Produced by Pyramidal Neurons Contributes to Neurovascular Coupling in the Rodent Cerebral Cortex.

Authors:  Alexandre Lacroix; Xavier Toussay; Eitan Anenberg; Clotilde Lecrux; Nerea Ferreirós; Anastassios Karagiannis; Fabrice Plaisier; Patrick Chausson; Frédéric Jarlier; Sean A Burgess; Elizabeth M C Hillman; Irmgard Tegeder; Timothy H Murphy; Edith Hamel; Bruno Cauli
Journal:  J Neurosci       Date:  2015-08-26       Impact factor: 6.167

10.  Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief.

Authors:  B Renner; G Walter; J Strauss; M F Fromm; J Zacher; K Brune
Journal:  Eur J Pain       Date:  2011-12-19       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.